FDA Expands Pfizer Booster Eligibility to Ages 12 and Up
By Deidre McPhillips, The US Food and Drug Administration on Monday expanded the emergency use authorization for Pfizer’s Covid-19 vaccine boosters to children ages 12 to 15. The agency also shortened the time needed before receiving a booster shot from at least six months after completion of the initial series to at least five months, for everyone 12 and older. “Throughout the pandemic, as the virus that causes Covid-19 has continuously evolved, the need for the FDA to quickly adapt has meant using the best available science to make informed decisions with the health and safety of the American public